SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Repurposing Drugs in Oncology: Next Steps
2 references·2 citing·14 second hop
Repurposing Drugs in Oncology: Next Steps (2017)Repurposing Drugs in Oncology: Next Stepsecancermedicalscience (2016)ecancermedicalscienceAccess to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries (2015)Access to Orphan Drugs: A Com…Repurposing drugs in oncology: From candidate selection to clinical adoption (2020)Repurposing drugs in oncology…On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients (2020)On-Label or Off-Label? Overco…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Clinical development success rates for investigational drugs (2014)Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)Drug repurposing in cancer research: a bibliometric analysis (2025)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Socio-economic burden of rare diseases: A systematic review of cost of illness evidence (2014)Overcoming Challenges Facing Advanced Therapies in the EU Market (2016)Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group (2018)Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy (2023)Drug repurposing in oncology—patient and health systems opportunities (2015)Entrez Direct: E-utilities on the UNIX Command Line (2016)Challenges and opportunities of drug repositioning (2013)Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics (2017)
this work references cited by second hop

References

  • 2015Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries278 cited
  • 2016ecancermedicalscience173 cited

Cited by

  • 2020On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients79 cited
  • 2020Repurposing drugs in oncology: From candidate selection to clinical adoption69 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work